PBM — Psyence Biomedical Cashflow Statement
0.000.00%
Last trade - 00:00- $1.96m
- $8.89m
Annual cashflow statement for Psyence Biomedical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final |
| Net Income/Starting Line | -1.85 | -3.21 | -51.2 |
| Depreciation | |||
| Non-Cash Items | 0.331 | 0.137 | 49.4 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.129 | 1.48 | -1.17 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Payable / Accrued Expenses | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -1.39 | -1.59 | -2.95 |
| Capital Expenditures | — | 0 | -0.006 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -0.032 | — | — |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -0.032 | 0 | -0.006 |
| Financing Cash Flow Items | -1.62 | 1.17 | 0 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -1.62 | 1.17 | 2.35 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -3.04 | -0.419 | -0.601 |